[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.79.216. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
September 2007

Focal Acne During Topical Tacrolimus Therapy for Vitiligo

Arch Dermatol. 2007;143(9):1209-1226. doi:10.1001/archderm.143.9.1223

Tacrolimus is a macrolide antibiotic produced by Streptomyces tsukubaensis and with strong T-specific immunosuppressant activity. Primarily used for treatment of atopic dermatitis, it has been used to treat other inflammatory and immunologic skin disorders, including vitiligo, with encouraging results.1 Focal hypertrichosis has been reported during topical tacrolimus therapy for childhood vitiligo,2 but acne does not seem to be a frequently reported adverse effect.

First Page Preview View Large
First page PDF preview
First page PDF preview
×